<img alt="" height="1" width="1" />Lexicon Pharmaceuticals buys Symphony IconBusinessWeekThe move gives Lexicon rights to LX1031 for irritable bowel syndrome, LX1032 for carcinoid syndrome, and LX1033 for other gastrointestinal disorders. ...Lexicon Pharmaceuticals Announces Reacquisition of All Rights to Symphony Icon ...<nobr>PR Newswire (press release)</nobr>Lexicon Pharmaceuticals buys Symphony Icon for $90M<nobr>Houston Business Journal</nobr><nobr>all 31 news articles »</nobr> |